Circulating long noncoding RNA as diagnostic and prognostic biomarkers for prostate cancer

As circulating Long non-coding RNAs (lncRNAs) are emerging as highly promising diagnostic and prognostic biomarkers, we hypothesise that analysis of prostate cancer relevant lncRNAs will lead to the identification of novel biomarkers for early diagnosis of prostate cancer and will also have discriminatory power to identify aggressive disease.

This project aims are:

  1. Analysis of prostate tumour and cell line RNAseq data to identify differentially regulated lncRNAs in aggressive prostate cancer.

  2. Evaluation of the biomarker potential of the circulating lncRNAs in early diagnosis of prostate cancer and to predict disease prognosis.


Jyotsna Batra  APCRC-Q, IHBI, QUT, TRI


2015 - 2016


Institute of Health and Biomedical Innovation, QUT $10 000

Upcoming Events

Feb 09, 2020 - Feb 13, 2020 ICONN 2020
Brisbane Convention and Exhibition Centre, Queensland
Feb 13, 2020 - Feb 15, 2020 ASCO Genitourinary Cancers Symposium 2020
Moscone West Building, San Francisco, USA
Mar 07, 2020 - Mar 10, 2020 USANZ 2020 Annual Scientific Meeting
International Convention Centre, Sydney, New South Wales
Mar 20, 2020 - Mar 24, 2020 EAU Congress 2020
RAI Amsterdam, The Netherlands
Mar 25, 2020 - Mar 29, 2020 World Science Festival Brisbane